In a new study of participants from the Medication use and Alzheimer's disease cohort, researchers investigated the impact of opioid initiation on the prevalence of antipsychotic and benzodiazepine...
Findings from 2 trials that compared various doses of the atypical antipsychotic brexpiprazole with placebo have indicated that the drug may have additional benefits for patients with agitation due to...
Researchers recently compared the effects of treatment with an atypical antipsychotic vs placebo for various periods of time among patients with Alzheimer disease psychosis.
Currently, little information is available regarding the clinical significance of anosognosia for cognitive decline in patients with mild cognitive impairment. In a new study, researchers assessed this...
Currently, little information is available regarding the clinical significance of anosognosia for cognitive decline in patients with mild cognitive impairment. In a new study, researchers assessed this...
Circadian rhythm disturbances are known to occur in patients with Alzheimer disease, but it is currently unclear whether they are present in patients with preclinical disease. The authors of a new study...
Previous research has suggested that anxiety, depression, and other neuropsychiatric symptoms could predict the progression of preclinical AD, which can occur more than a decade before cognitive impairment...
Previous research has suggested that anxiety, depression, and other neuropsychiatric symptoms could predict the progression of preclinical AD, which can occur more than a decade before cognitive impairment...
Cerebral amyloid-β aggregation is a known sign of early Alzheimer disease. However, an ongoing study now aims to determine whether this type of aggregation could be linked to cognitive function and related...
